Etiketter

Summa sidvisningar

Sidor

Leta i den här bloggen

fredag 11 januari 2019

Mikä geenitausta on hyperfosfatemisen tumoraalin kalsinoosin takana?

1.  hakusana Hyperphosphataemic tumoral calcinosis
2. Ilmenee geeni GLNT3 mutaatioita   Katon lopuksi GALNT3 geenin ihmisellä

2007

2006 Nov;91(11):4472-5. Epub 2006 Aug 29.
Tumoral calcinosis presenting with eyelid calcifications due to novel missense mutations in the glycosyl transferase domain of the GALNT3 gene.

2009

2009 Jun;150(6):2543-50. doi: 10.1210/en.2008-0877. Epub 2009 Feb 12.
Ablation of the Galnt3 gene leads to low-circulating intact fibroblast growth factor 23 (Fgf23) concentrations and hyperphosphatemia despite increased Fgf23 expression.

 2011

https://www.ncbi.nlm.nih.gov/pubmed/22009723/
2011 Dec;152(12):4504-13. doi: 10.1210/en.2011-1137. Epub 2011 Oct 18.
Dietary phosphate restriction normalizes biochemical and skeletal abnormalities in a murine model of tumoral calcinosis.
 
2014 
 

2014 Sep 24;15:98. doi: 10.1186/s12863-014-0098-3.
Long-term clinical outcome and phenotypic variability in hyperphosphatemic familial tumoral calcinosis and hyperphosphatemic hyperostosis syndrome caused by a novel GALNT3 mutation; case report and review of the literature.
 
 2015 

2015 Apr;13(2):78-87. doi: 10.1007/s11914-015-0254-3.
Hyperphosphatemic familial tumoral calcinosis: genetic models of deficient FGF23 action.
 
 2016

 https://www.ncbi.nlm.nih.gov/pubmed/27164190
2016 Oct;31(10):1845-1854. doi: 10.1002/jbmr.2870. Epub 2016 Sep 20.
Phenotypic and Genotypic Characterization and Treatment of a Cohort With Familial Tumoral Calcinosis/Hyperostosis-Hyperphosphatemia Syndrome.
 
 

Inga kommentarer: